SI1003554T1 - Proton pump inhibitor in therapeutic combination with antibacterial substances - Google Patents

Proton pump inhibitor in therapeutic combination with antibacterial substances

Info

Publication number
SI1003554T1
SI1003554T1 SI9830734T SI9830734T SI1003554T1 SI 1003554 T1 SI1003554 T1 SI 1003554T1 SI 9830734 T SI9830734 T SI 9830734T SI 9830734 T SI9830734 T SI 9830734T SI 1003554 T1 SI1003554 T1 SI 1003554T1
Authority
SI
Slovenia
Prior art keywords
proton pump
pump inhibitor
therapeutic combination
antibacterial substances
antibacterial
Prior art date
Application number
SI9830734T
Other languages
English (en)
Slovenian (sl)
Inventor
Klaus Tuch
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of SI1003554T1 publication Critical patent/SI1003554T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI9830734T 1997-07-25 1998-07-21 Proton pump inhibitor in therapeutic combination with antibacterial substances SI1003554T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97112795 1997-07-25
EP98942585A EP1003554B1 (fr) 1997-07-25 1998-07-21 Inhibiteur de la pompe a protons en combinaison therapeutique avec des substances antibacteriennes
PCT/EP1998/004553 WO1999004816A1 (fr) 1997-07-25 1998-07-21 Inhibiteur de la pompe a protons en combinaison therapeutique avec des substances antibacteriennes

Publications (1)

Publication Number Publication Date
SI1003554T1 true SI1003554T1 (en) 2005-04-30

Family

ID=8227119

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830734T SI1003554T1 (en) 1997-07-25 1998-07-21 Proton pump inhibitor in therapeutic combination with antibacterial substances

Country Status (9)

Country Link
US (1) US6303644B1 (fr)
EP (1) EP1003554B1 (fr)
AT (1) ATE281178T1 (fr)
AU (1) AU9067198A (fr)
DE (1) DE69827392T2 (fr)
ES (1) ES2232015T3 (fr)
PT (1) PT1003554E (fr)
SI (1) SI1003554T1 (fr)
WO (1) WO1999004816A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026210A2 (fr) * 2000-09-29 2002-04-04 Geneva Pharmaceuticals Inc. Formulation d'inhibiteur de la pompe à protons
US20050165041A1 (en) * 2002-05-07 2005-07-28 Altana Pharma Ag Combination for the treatment of airway disorders
AU2003227710A1 (en) * 2002-05-07 2003-11-11 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20060194748A1 (en) * 2005-02-28 2006-08-31 National University Corporation Nagoya University Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same
GB2479120A (en) 2010-03-26 2011-10-05 Cambridge Display Tech Ltd Organic electrolumunescent device having conductive layer connecting metal over well defining layer and cathode

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
US5149702A (en) 1989-11-29 1992-09-22 Toa Eiyo Ltd. Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same
GB9018603D0 (en) * 1990-08-24 1990-10-10 Smith Kline French Lab Compositions
US5352688A (en) 1991-02-14 1994-10-04 The Mount Sinai School Of Medicine Of The City University Of New York Methods for the treatment of bradyphrenia in parkinson's disease
WO1993012817A1 (fr) 1991-12-20 1993-07-08 Warner-Lambert Company Combinaisons therapeutiques utiles dans le traitement du reflux gastro-×sophagien
IL105155A (en) * 1992-04-24 1999-05-09 Astra Ab Synergistic combination of an inhibitor of gastric acid secretion with an acid-breaking antibiotic
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
JPH09188624A (ja) * 1996-01-06 1997-07-22 Takeshi Azuma 肝性脳症治療剤又は肝性脳症予防剤
US6134344A (en) * 1997-06-26 2000-10-17 Lucent Technologies Inc. Method and apparatus for improving the efficiency of support vector machines

Also Published As

Publication number Publication date
ATE281178T1 (de) 2004-11-15
ES2232015T3 (es) 2005-05-16
DE69827392D1 (de) 2004-12-09
EP1003554B1 (fr) 2004-11-03
US6303644B1 (en) 2001-10-16
DE69827392T2 (de) 2005-10-27
PT1003554E (pt) 2005-03-31
EP1003554A1 (fr) 2000-05-31
AU9067198A (en) 1999-02-16
WO1999004816A1 (fr) 1999-02-04

Similar Documents

Publication Publication Date Title
MY138059A (en) Use of ikb-kinase inhibitors in pain therapy
DE60210093D1 (de) Beta-amino-tetrahydroimidazo(1,2-a)pyrazine und -tetrahydrotriazolo(4,3-a)pyrazine als dipeptidyl peptidase inhibitoren zur behandlung oder prevention von diabetes
TR200001203T2 (tr) Yeni birleşik maddeler
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
MXPA05006359A (es) Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos.
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
WO2005037323A3 (fr) Methode pour inhiber une signalisation de nf-kappa b et son utilisation pour traiter et pour prevenir des maladies humaines
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
MXPA04003674A (es) Uso mejorado de compuesto antitumoral en terapia de cancer.
EP1631297A4 (fr) Traitement des maladies a mediation immunologique au moyen de composes a base de vitamine d active, seuls ou en association avec d'autres agents therapeutiques
AU2001246600A1 (en) Use of comt inhibitors as analgesics
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
HK1029944A1 (en) Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
SI1003554T1 (en) Proton pump inhibitor in therapeutic combination with antibacterial substances
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.
NZ519722A (en) Treatment of diabetic ulcers
IL139144A0 (en) Mycobacterial inhibitors
HK1079116A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
GB9626472D0 (en) New use of comt inhibitors
RS95304A (en) New combination fortreating airway disorders
PT1212119E (pt) Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas
MXPA02006863A (es) Compuestos de pirrol fusionados, composiciones farmaceuticas que los comprenden y su uso.
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen